DAVITA INC (DVA) Stock Price, Forecast & Analysis
USA - NYSE:DVA - US23918K1088 - Common Stock
DVA Key Statistics, Chart & Performance
The current stock price of DVA is 122.55 USD. In the past month the price decreased by -1.76%. In the past year, price decreased by -23.25%.
DVA Latest News, Press Relases and Analysis
DVA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.5 | 99.88B | ||
| CI | THE CIGNA GROUP | 9.5 | 72.06B | ||
| LH | LABCORP HOLDINGS INC | 16.92 | 22.25B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.15 | 20.90B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 106.96 | 19.33B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.80B | ||
| HIMS | HIMS & HERS HEALTH INC | 69.89 | 8.53B | ||
| CHE | CHEMED CORP | 20 | 6.41B | ||
| RDNT | RADNET INC | 198.78 | 5.81B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 31.67 | 5.72B | ||
| OPCH | OPTION CARE HEALTH INC | 18.99 | 4.59B | ||
| CRVL | CORVEL CORP | 36.54 | 3.81B |
Related stock screener links
About DVA
Company Profile
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 76,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Company Info
DAVITA INC
2000 16th St
Denver COLORADO 80202 US
CEO: Javier J. Rodriguez
Employees: 76000
Phone: 13105362668
DAVITA INC / DVA FAQ
What does DAVITA INC do?
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 76,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Can you provide the latest stock price for DAVITA INC?
The current stock price of DVA is 122.55 USD. The price decreased by -0.41% in the last trading session.
What is the dividend status of DAVITA INC?
DVA does not pay a dividend.
What is the ChartMill rating of DAVITA INC stock?
DVA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the valuation of DAVITA INC (DVA) based on its PE ratio?
The PE ratio for DAVITA INC (DVA) is 13.28. This is based on the reported non-GAAP earnings per share of 9.23 and the current share price of 122.55 USD.
What is the market capitalization of DVA stock?
DAVITA INC (DVA) has a market capitalization of 8.76B USD. This makes DVA a Mid Cap stock.
Can you provide the ownership details for DVA stock?
You can find the ownership structure of DAVITA INC (DVA) on the Ownership tab.
DVA Technical Analysis
DVA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DVA. DVA has an excellent profitability rating, but there are concerns on its financial health.
DVA Financial Highlights
Over the last trailing twelve months DVA reported a non-GAAP Earnings per Share(EPS) of 9.23. The EPS increased by 3.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.8% | ||
| ROA | 4.4% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
DVA Forecast & Estimates
17 analysts have analysed DVA and the average price target is 153.54 USD. This implies a price increase of 25.29% is expected in the next year compared to the current price of 122.55.
For the next year, analysts expect an EPS growth of 16.39% and a revenue growth 5.62% for DVA